CureVac SE
CureVac is a pioneer in the field of development and production of a completely new class of therapies based on the messenger molecule mRNA.
Lobbying Activity
Meeting with Cristian-Silviu Buşoi (Member of the European Parliament)
28 Jun 2023 · ongoing work in oncology and innovation
Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)
30 Nov 2022 · Medicines manufacturing and pandemic preparedness
Meeting with Karsten Lucke (Member of the European Parliament)
21 Nov 2022 · Corona Impfstoffe
Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair)
8 Sept 2022 · Lessons learned from the COVID-19 pandemic and the work of the COVI Committee
Response to Ex-post evaluation of the Horizon 2020 framework programme for Research and Innovation
29 Jul 2022
Meeting with Thierry Breton (Commissioner)
2 Mar 2021 · Vaccine production
Meeting with Sandra Gallina (Director-General Health and Food Safety)
8 Feb 2021 · meeting with Curevac - vaccines
Meeting with Ursula von der Leyen (President) and
31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements
Meeting with Mariya Gabriel (Commissioner)
6 Jul 2020 · CureVac Signature
Meeting with Ursula von der Leyen (President)
16 Mar 2020 · Videconderence with CureVac representatives on COVID-19
Meeting with Mariya Gabriel (Commissioner)
16 Mar 2020 · COVID-19